Tirzepatide

From WikiAlpha
Jump to: navigation, search
Tirzepatide
Area served Manufacturer
Website Polypeptide.ltd
Tirzepatide

Tirzepatide

List of Suppliers

Polypeptide [1]

Tirzepatide is a synthetic derivative that combines the functionalities of gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). This unique combination enables Tirzepatide to effectively lower blood glucose levels, improve insulin sensitivity, promote feelings of satiety, and facilitate weight loss. Initially developed as a treatment for type 2 diabetes, Tirzepatide has also demonstrated the ability to protect the cardiovascular system and act as a potent agent for weight loss.

Product Details of [ Tirzepatide ]

  • Name:Tirzepatide
  • Amino Acid Sequence: YE-Aib-GTFTSDYSI-Aib-LDKIAQ (C20 fty acid) AFVQWLIAGGPSSGAPPPS
  • Note: Aib is a non-coded (non-proteinogenic) amino acid – H2H-C(CH3)2 COOH
  • Molecular Formula: C225H348N48O68
  • Molecular Weight: 4813.527 g/mol
  • PubChem CID: 156588324
  • CAS Number: 2023788-19-2
  • Synonyms: P1206, LY3298176

Tirzepatide Research

In simple terms, Tirzepatide enhances insulin release from the pancreas, leading to improved glucose regulation. Studies demonstrate that in individuals with Type 2 diabetes, Tirzepatide reduces hemoglobin A1c (HbA1c) levels by 2.4% within six months. Additionally, the peptide has shown a dose-dependent relationship in promoting weight loss, with individuals losing up to 11 kg (25 lbs) over a six-month period . [2] Tirzepatide not only increases insulin release but also improves the functionality of pancreatic beta cells, which are responsible for producing and releasing insulin. Research indicates that Tirzepatide may enhance the effectiveness of beta cells in processing insulin, resulting in both elevated insulin levels in the bloodstream and reduced stress on the beta cells. This effect has the potential to slow down the progression of type 2 diabetes.

Research indicates that Tirzepatide does not indiscriminately raise insulin levels but responds specifically to elevated blood glucose levels. Interestingly, during fasting, Tirzepatide actually reduces insulin levels, contributing to improved insulin sensitivity over time. Additionally, it lowers fasting levels of glucagon, a hormone that can disrupt hepatic glucose metabolism and worsen hyperglycemia. These effects play a significant role in Tirzepatide’s ability to effectively regulate glucose levels and ultimately lower HbA1c levels.

Storage

Sealed in dry,Room Temperature

Manufacturer

Best peptides Tirzepatide 5mg & 10mg Manufacturers - Polypeptide


References